{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T15:27:47Z","timestamp":1776007667485,"version":"3.50.1"},"publisher-location":"Cham","reference-count":38,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783319717784","type":"print"},{"value":"9783319717791","type":"electronic"}],"license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018]]},"DOI":"10.1007\/978-3-319-71779-1_6","type":"book-chapter","created":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T04:51:01Z","timestamp":1518151861000},"page":"135-145","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Spinocerebellar Ataxia Type 1: Molecular Mechanisms of Neurodegeneration and Preclinical Studies"],"prefix":"10.1007","author":[{"given":"Judit M.","family":"P\u00e9rez Ortiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry T.","family":"Orr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,2,10]]},"reference":[{"issue":"3","key":"6_CR1","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S0888-7543(05)80365-9","volume":"18","author":"S Banfi","year":"1993","unstructured":"Banfi S et al (1993) Mapping and cloning of the critical region for the spinocerebellar ataxia Type 1 gene (SCA1) in a yeast artificial chromosome contig spanning 1.2 Mb. Genomics 18(3):627\u2013635","journal-title":"Genomics"},{"issue":"3","key":"6_CR2","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1038\/ng0793-221","volume":"4","author":"HT Orr","year":"1993","unstructured":"Orr HT et al (1993) Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat Genet 4(3):221\u2013226","journal-title":"Nat Genet"},{"issue":"3","key":"6_CR3","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/ng1193-254","volume":"5","author":"MY Chung","year":"1993","unstructured":"Chung MY et al (1993) Evidence for a mechanism predisposing to intergenerational CAG repeat instability in spinocerebellar ataxia type I. Nat Genet 5(3):254\u2013258","journal-title":"Nat Genet"},{"issue":"1","key":"6_CR4","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/S0092-8674(00)81781-X","volume":"95","author":"IA Klement","year":"1998","unstructured":"Klement IA et al (1998) Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice. Cell 95(1):41\u201353","journal-title":"Cell"},{"issue":"6","key":"6_CR5","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1101\/gad.212068.112","volume":"27","author":"E Kim","year":"2013","unstructured":"Kim E, Lu HC, Zoghbi HY (2013) Structural basis of protein complex formation and reconfiguration by polyglutamine disease protein ataxin-1 and capicua. Genes Dev 27(6):590\u2013595","journal-title":"Genes Dev"},{"issue":"7","key":"6_CR6","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1016\/j.cell.2006.11.038","volume":"127","author":"YC Lam","year":"2006","unstructured":"Lam YC et al (2006) ATAXIN-1 interacts with the repressor capicua in Its native complex to cause SCA1 neuropathology. Cell 127(7):1335\u20131347","journal-title":"Cell"},{"issue":"6","key":"6_CR7","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/S0896-6273(02)00733-X","volume":"34","author":"K Watase","year":"2002","unstructured":"Watase K et al (2002) A long CAG repeat in the mouse Sca1 locus replicates SCA1 features and reveals the impact of protein solubility on selective neurodegeneration. Neuron 34(6):905\u2013919","journal-title":"Neuron"},{"issue":"6","key":"6_CR8","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.neuron.2010.08.022","volume":"67","author":"Lisa Duvick","year":"2010","unstructured":"Duvick Lisa et al (2010) SCA1-like disease in mice expressing wild-type ataxin-1 with a serine to aspartic acid replacement at residue 776. Neuron 67(6):929\u2013935","journal-title":"Neuron"},{"issue":"3","key":"6_CR9","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/S0896-6273(03)00258-7","volume":"38","author":"ES Emamian","year":"2003","unstructured":"Emamian ES et al (2003) Serine 776 of Ataxin-1 is critical for polyglutamine-induced disease in SCA1 transgenic mice. Neuron 38(3):375\u2013387","journal-title":"Neuron"},{"issue":"6808","key":"6_CR10","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/35040584","volume":"408","author":"P Fernandez-Funez","year":"2000","unstructured":"Fernandez-Funez P et al (2000) Identification of genes that modify Ataxin-1-induced neurodegeneration. Nature 408(6808):101\u2013106","journal-title":"Nature"},{"issue":"6","key":"6_CR11","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.cell.2015.02.012","volume":"160","author":"VA Gennarino","year":"2015","unstructured":"Gennarino VA et al (2015) Pumilio1 haploinsufficiency leads to SCA1-like neurodegeneration by increasing wild-type Ataxin1 levels. Cell 160(6):1087\u20131098","journal-title":"Cell"},{"issue":"2","key":"6_CR12","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/j.1471-4159.2009.06164.x","volume":"110","author":"ND Jorgensen","year":"2009","unstructured":"Jorgensen ND et al (2009) Phosphorylation of ATXN1 at Ser776 in the cerebellum. J Neurochem 110(2):675\u2013686","journal-title":"J Neurochem"},{"issue":"4","key":"6_CR13","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/S0092-8674(03)00349-0","volume":"113","author":"HK Chen","year":"2003","unstructured":"Chen HK et al (2003) Interaction of Akt-phosphorylated Ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1. Cell 113(4):457\u2013468","journal-title":"Cell"},{"issue":"5","key":"6_CR14","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1073\/pnas.1018748108","volume":"108","author":"P Jafar-nejad","year":"2011","unstructured":"Jafar-nejad P, Ward CS, Richman R, Orr HT, Zoghbi HY (2011) Regional rescue of spinocerebellar ataxia type 1 phenotypes by 14-3-3 \u03b5 haploinsufficiency in mice underscores complex pathogenicity in neurodegeneration. PNAS 108(5):2142\u20132147","journal-title":"PNAS"},{"issue":"40","key":"6_CR15","doi-asserted-by":"publisher","first-page":"34606","DOI":"10.1074\/jbc.M111.238527","volume":"286","author":"S Lai","year":"2011","unstructured":"Lai S, O\u2019Callaghan B, Zoghbi HY, Orr HT (2011) 14-3-3 binding to ataxin-1 (ATXN1) regulates its dephosphorylation at Ser-776 and transport to the nucleus. J Biol Chem 286(40):34606\u201334616","journal-title":"J Biol Chem"},{"issue":"7188","key":"6_CR16","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1038\/nature06731","volume":"452","author":"J Lim","year":"2008","unstructured":"Lim J et al (2008) Opposing effects of polyglutamine expansion on native protein complexes contribute to SCA1. Nature 452(7188):713\u2013718","journal-title":"Nature"},{"key":"6_CR17","doi-asserted-by":"crossref","unstructured":"Masuda A, Takeda JI, Ohno K (2016) FUS-mediated regulation of alternative RNA processing in neurons: insights from global transcriptome analysis. Wiley Interdiscip Rev RNA 2\u20135","DOI":"10.1002\/wrna.1338"},{"issue":"4","key":"6_CR18","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1261\/rna.052795.115","volume":"22","author":"N S\u00e1nchez-hern\u00e1ndez","year":"2016","unstructured":"S\u00e1nchez-hern\u00e1ndez N et al (2016) The in vivo dynamics of TCERG1, a factor that couples transcriptional elongation with splicing. RNA 22(4):571\u2013582","journal-title":"RNA"},{"issue":"2","key":"6_CR19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/72101","volume":"3","author":"X Lin","year":"2000","unstructured":"Lin X, Antalffy B, Kang D, Orr HT, Zoghbi HY (2000) Polyglutamine expansion down-regulates specific neuronal genes before pathologic changes in SCA1. Nat Neurosci 3(2):157\u2013163","journal-title":"Nat Neurosci"},{"issue":"20","key":"6_CR20","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1093\/hmg\/ddh268","volume":"13","author":"HG Serra","year":"2004","unstructured":"Serra HG et al (2004) Gene profiling links SCA1 pathophysiology to glutamate signaling in purkinje cells of transgenic mice. Hum Mol Genet 13(20):2535\u20132543","journal-title":"Hum Mol Genet"},{"issue":"40","key":"6_CR21","doi-asserted-by":"publisher","first-page":"8853","DOI":"10.1523\/JNEUROSCI.2978-04.2004","volume":"24","author":"Tao Zu","year":"2004","unstructured":"Zu Tao et al (2004) Recovery from polyglutamine-induced neurodegeneration in conditional SCA1 transgenic mice. J Neurosci Off J Soc Neurosci 24(40):8853\u20138861","journal-title":"J Neurosci Off J Soc Neurosci"},{"issue":"3","key":"6_CR22","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/j.1471-4159.2010.06791.x","volume":"114","author":"SM Hearst","year":"2010","unstructured":"Hearst SM, Lopez ME, Shao Q, Liu Y, Vig PJS (2010) Dopamine D2 receptor signaling modulates mutant ataxin-1 S776 phosphorylation and aggregation. J Neurochem 114(3):706\u2013716","journal-title":"J Neurochem"},{"issue":"11","key":"6_CR23","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1038\/nm.2494","volume":"17","author":"M Cvetanovic","year":"2011","unstructured":"Cvetanovic M, Patel JM, Marti HH, K AR, Opal P (2011) Vascular endothelial growth factor ameliorates the ataxic phenotype in a mouse model of spinocerebellar ataxia type 1. Nat Med 17(11):1445\u20131447","journal-title":"Nat Med"},{"issue":"1","key":"6_CR24","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.neuron.2015.11.033","volume":"89","author":"C Ruegsegger","year":"2016","unstructured":"Ruegsegger C et al (2016) Impaired mTORC1-dependent expression of homer-3 influences SCA1 pathophysiology. Neuron 89(1):129\u2013146","journal-title":"Neuron"},{"issue":"4","key":"6_CR25","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.cell.2006.09.036","volume":"127","author":"HG Serra","year":"2006","unstructured":"Serra HG et al (2006) RORa-mediated purkinje cell development determines disease severity in adult SCA1 mice. Cell 127(4):697\u2013708","journal-title":"Cell"},{"issue":"13","key":"6_CR26","doi-asserted-by":"publisher","first-page":"5806","DOI":"10.1523\/JNEUROSCI.6311-11.2013","volume":"33","author":"BA Ebner","year":"2013","unstructured":"Ebner BA et al (2013) Purkinje cell ataxin-1 modulates climbing fiber synaptic input in developing and adult mouse cerebellum. J Neurosci 33(13):5806\u20135820","journal-title":"J Neurosci"},{"issue":"6","key":"6_CR27","doi-asserted-by":"publisher","first-page":"1194","DOI":"10.1016\/j.neuron.2016.02.011","volume":"89","author":"Melissa Ingram","year":"2016","unstructured":"Ingram M, et al (2016) Cerebellar transcriptome profiles of ATXN1 transgenic mice reveal SCA1 disease progression and protection pathways. Neuron 1194\u20131207","journal-title":"Neuron"},{"issue":"1\u20132","key":"6_CR28","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/S0925-4773(01)00471-3","volume":"108","author":"T Acker","year":"2001","unstructured":"Acker T, Beck H, Plate KH (2001) Cell type specific expression of vascular endothelial growth factor and Angiopoietin-1 and -2 suggests an important role of astrocytes in cerebellar vascularization. Mech Dev 108(1\u20132):45\u201357","journal-title":"Mech Dev"},{"issue":"45","key":"6_CR29","doi-asserted-by":"publisher","first-page":"15052","DOI":"10.1523\/JNEUROSCI.0477-10.2010","volume":"30","author":"CR Almodovar de","year":"2010","unstructured":"de Almodovar CR et al (2010) Matrix-binding vascular endothelial growth factor (VEGF) isoforms guide granule cell migration in the cerebellum via VEGF receptor Flk1. J Neurosci 30(45):15052\u201315066","journal-title":"J Neurosci"},{"issue":"36","key":"6_CR30","doi-asserted-by":"publisher","first-page":"12778","DOI":"10.1523\/JNEUROSCI.2579-11.2011","volume":"31","author":"JA Barnes","year":"2011","unstructured":"Barnes JA et al (2011) Abnormalities in the climbing fiber-purkinje cell circuitry contribute to neuronal dysfunction in ATXN1[82Q] mice. J Neurosci Off J Soc Neurosci 31(36):12778\u201312789","journal-title":"J Neurosci Off J Soc Neurosci"},{"issue":"7454","key":"6_CR31","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nature12204","volume":"498","author":"J Park","year":"2013","unstructured":"Park J et al (2013) RAS-MAPK-MSK1 pathway modulates ataxin 1 protein levels and toxicity in SCA1. Nature 498(7454):325\u2013331","journal-title":"Nature"},{"issue":"8","key":"6_CR32","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1038\/nm1076","volume":"10","author":"H Xia","year":"2004","unstructured":"Xia H et al (2004) RNAi suppresses polyglutamine-induced neurodegeneration in a model of spinocerebellar ataxia. Nat Med 10(8):816\u2013820","journal-title":"Nat Med"},{"issue":"1","key":"6_CR33","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/mt.2008.231","volume":"17","author":"RL Boudreau","year":"2009","unstructured":"Boudreau RL, Martins I, Davidson BL (2009) Artificial microRNAs as siRNA shuttles: improved safety as compared to shRNAs in Vitro and in Vivo. Mol Ther J Am Soc Gene Ther 17(1):169\u2013175","journal-title":"Mol Ther J Am Soc Gene Ther"},{"issue":"15","key":"6_CR34","doi-asserted-by":"publisher","first-page":"5868","DOI":"10.1073\/pnas.0801775105","volume":"105","author":"JL McBride","year":"2008","unstructured":"McBride JL et al (2008) Artificial miRNAs Mitigate shRNA-mediated toxicity in the brain: implications for the therapeutic development of RNAi. Proc Natl Acad Sci USA 105(15):5868\u20135873","journal-title":"Proc Natl Acad Sci USA"},{"key":"6_CR35","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.nbd.2013.04.003","volume":"56C","author":"MS Keiser","year":"2013","unstructured":"Keiser MS, Geoghegan JC, Boudreau RL, Lennox KA, Davidson BL (2013) RNAi or overexpression: alternative therapies for spinocerebellar ataxia type 1. Neurobiol Dis 56C:6\u201313","journal-title":"Neurobiol Dis"},{"key":"6_CR36","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1038\/mt.2013.279","volume":"2","author":"MS Keiser","year":"2014","unstructured":"Keiser MS, Boudreau RL, Davidson BL (2014) Broad therapeutic benefit after RNAi expression vector delivery to deep cerebellar nuclei: implications for spinocerebellar ataxia type 1 therapy. Mol Ther 2:588\u2013595","journal-title":"Mol Ther"},{"issue":"6","key":"6_CR37","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.1016\/j.neuron.2012.05.009","volume":"74","author":"HB Kordasiewicz","year":"2012","unstructured":"Kordasiewicz HB et al (2012) Sustained therapeutic reversal of huntington\u2019s disease by transient repression of huntingtin synthesis. Neuron 74(6):1031\u20131044","journal-title":"Neuron"},{"issue":"5","key":"6_CR38","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S1474-4422(13)70061-9","volume":"12","author":"TM Miller","year":"2013","unstructured":"Miller TM et al (2013) An antisense oligonucleotide against SOD1 delivered intrathecally for patients with SOD1 familial amyotrophic lateral sclerosis: a phase 1, randomised, first-in-man study. Lancet Neurol 12(5):435\u2013442","journal-title":"Lancet Neurol"}],"container-title":["Advances in Experimental Medicine and Biology","Polyglutamine Disorders"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-319-71779-1_6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,4,9]],"date-time":"2018-04-09T23:28:57Z","timestamp":1523316537000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-3-319-71779-1_6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"ISBN":["9783319717784","9783319717791"],"references-count":38,"URL":"https:\/\/doi.org\/10.1007\/978-3-319-71779-1_6","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018]]}}}